Traws Pharma Q2 2025 GAAP EPS $(0.11) Up From $(20.52) YoY, Sales $2.733M Up From $57.000K YoY

Traws Pharma (NASDAQ: TRAW) reported quarterly losses of $(0.11) per share. This is a 99.46 percent increase over losses of $(20.52) per share from the same period last year. The company reported $2.733 million in sales this quarter. This is a 4.69K percent increase over sales of $57.000 thousand the same period last year.